Results 141 to 150 of about 6,174 (184)

A plain language summary of the preliminary results for encorafenib plus binimetinib and pembrolizumab in adults with BRAF V600-mutant melanoma in the STARBOARD study. [PDF]

Future Oncol
Dudnichenko O, Penkov K, McKean M, Mandalà M, Kukushkina M, Panella T, Csőszi T, Gerletti P, Thakur M, Poll A, di Pietro A, Schadendorf D.   +11 more
europepmc   +1 more source

FGFR signaling and neddylation facilitate SARS-CoV-2 infection by modulating interferon induction and viral entry, respectively. [PDF]

iScience
Felix-Lopez A, Lopez-Orozco J, Elaish M, Fayad N, Xu Z, Woldemariam T, Hassan BB, Panigrahi R, Khan JQ, Rohamare M, Mayers I, Glover JNM, Wilson JA, Falzarano D, Kumar A, Hobman TC.   +15 more
europepmc   +1 more source

Pembrolizumab in Combination with Binimetinib in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer. [PDF]

Clin Cancer Res
Chumsri S, Larson JJ, Liu E, Tenner KS, Adams D, Weidner MT, Arnold AN, Haley DL, Advani P, Sideras K, Moreno-Aspitia A, Thompson EA, Perez EA, Knutson KL.   +13 more
europepmc   +1 more source

A single-center retrospective study of dabrafenib plus trametinib combination therapy in patients with BRAF V600E-positive thyroid cancer. [PDF]

Int J Clin Oncol
Ando T, Oya Y, Tomiie Y, Ogawa K, Kuki T, Tanabe Y, Kato H, Imaizumi K, Hibi Y, Kawada K.   +9 more
europepmc   +1 more source

Surrogate to predict overall survival in patients with <i>BRAF</i> V600E-mutant colorectal cancer treated with BRAF inhibitor combinations. [PDF]

ESMO Gastrointest Oncol
Ros J, Navarro V, Villacampa G, Baraibar I, Salvà F, Rodriguez M, Vaghi C, Garcia A, Alcaraz A, Tabernero J, Élez E, Dienstmann R.   +11 more
europepmc   +1 more source

Perforated primary adenocarcinoma of the colon with choriocarcinoma differentiation treated with targeted colorectal cancer chemotherapy: a case report. [PDF]

AME Case Rep
Ishimaru N, Tagami T, Yamasaki M, Niwa K.   +3 more
europepmc   +1 more source

The Absorption, Distribution, Metabolism, and Excretion of Binimetinib Following a Single Oral Dose of [¹⁴C]Binimetinib 45 mg in Healthy Male Participants. [PDF]

Pharmacol Res Perspect
Huynh D, Hahn E, Reddy MB, Chavira R, Wollenberg L.   +4 more
europepmc   +1 more source

Post-marketing surveillance of encorafenib in combination with binimetinib in Japanese patients with BRAF-mutant melanoma. [PDF]

Int J Clin Oncol
Yamazaki N, Sakata H, Iida O, Katayama T, Uhara H.   +4 more
europepmc   +1 more source

NRAS and SREBF1 identified as mitophagy-associated risk genes for rheumatoid arthritis through interpretable machine learning and experimental validation studies. [PDF]

BMC Rheumatol
Li H, Liu P, Han X, Si S, Li Z, Zhao C, Zhao X, Zhou X, Liu M.   +8 more
europepmc   +1 more source